Where Debate & Discussion Translate to Breakthroughs. Now Offering 2 Locations. Greatdebatesinhema.com

Similar documents
October 17 20, 2018 New York City. An International Congress on Lymphoma, Myeloma, and Leukemia Disorders

October 12 13, 2018 New York Marriott Marquis New York, New York. The premier conference for annual updates in lung cancer. 23rd Annual Conference

Clinical Breakthroughs & Challenges In Hematologic Malignancies

2018 UPDATE IN HEMATOLOGIC MALIGNANCIES with Proceedings from International Medical Meetings

LEUKEMIAS 2017 ACUTE & CHRONIC ENCORE AT WYNN LAS VEGAS LAS VEGAS, NEVADA OCTOBER 6 7, 2017

2019 UPDATES IN CARE OF THE HEMATOLOGIC MALIGNANCIES PATIENT: with Proceedings from International Medical Meetings

15 th Annual Indy Hematology Review

4 th International Conference on Advances in Hematology and Oncology

16 th Annual Indy Hematology Review

SATURDAY, NOVEMBER 4, :00 AM 4:30 PM

JANUARY 22, :00 AM 4:30 PM

& ONCOLOGY HEMATOLOGY. Clinical Multidisciplinary. The 15th Annual Review

CME. Controversies in Hematologic Malignancies. Annual Oncology Symposium: Friday, May 20, 2016

With Proceedings from International Medical Meetings

HEMATOLOGY & ONCOLOGY REVIEWS 19th Annual Fellows Research Presentations

ONCO- NEPHROLOGY SYMPOSIUM DECEMBER 1, Memorial Sloan Kettering Cancer Center Zuckerman Research Center 417 East 68 th Street New York, NY 10065

Type 1 Diabetes: New and Emerging Therapeutic Strategies to Address Unmet Needs

ONCOLOGY PATHOLOGY. 2Annual International Congress on. Saturday, June 23. To register visit. Updated Agenda and Faculty inside

CARE OF THE OLDER ADULT ACROSS THE CANCER CONTINUUM

Charles L. Spurr Piedmont Oncology Symposium

ONCOLOGY AND MALIGNANT HEMATOLOGY REVIEW CONFERENCE

Bridging Treatment to Transplant and Current Advances

PATHOLOGY. UPDATE 2018 What you need to know about new AJCC staging and WHO classifications

Best of Radiation Oncology

Highlights from the 2017 Annual Meeting of the American Society of Hematology

CONTENTS. Sponsors. Introduction Letter. Program Agenda. Faculty Listing. Notes

Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer

5 TH ANNUAL PERSPECTIVES IN RHEUMATIC DISEASES

Fifth Annual Advances in Pulmonary and Critical Care Medicine CME Symposium

SBRT IN THE MANAGEMENT OF PROSTATE CANCER SATELLITE SYMPOSIUM AT THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) 2018 ANNUAL MEETING ADVANCES IN

Current Topics in Breast Cancer Symposium

8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina

INNOVATIONS IN BRAIN TUMOR MANAGEMENT

Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center. June 22-23, 2018

Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center. June 22-23, 2018

MAY 5-6, Crowne Plaza Times Square NEW YORK, NY

Multidisciplinary Spine Oncology Symposium

Palliative Medicine and Supportive Oncology 2014 The 17th International Symposium

MEMORIAL LECTURE & RESIDENT ABSTRACT COMPETITION 6TH ANNUAL DR. JOHN MORDENTE WEDNESDAY, OCTOBER 18, :00 PM 9:30 PM

TOLEARN: 3 WAYS. LIVE meetings are produced. ONLINE products are produced by. PRINT materials are produced by. by Imedex in 15 countries

CARDHOLDER S NAME SIGNATURE CARD NUMBER EXP. DATE. Nurses/Residents/Students* (*proof of eligibility must accompany registration)...

INTERNATIONAL MYELOMA SOCIETY EDUCATIONAL WORKSHOP. October 27-28, 2017 Gaylord National Hotel Washington, D.C. Metro Area

Thursday, September 14, 2017 University of Charleston Geary Student Union Building 3rd Floor Ballroom Charleston, WV

HODGKIN S AND NON-HODGKIN S LYMPHOMA

UPDATES IN ONCOLOGY 2018 PHILADELPHIA with Proceedings from International Medical Meetings

RECOGNIZING & ASSESSING COGNITIVE IMPAIRMENT SYMPOSIUM

TCOYD Regional Meeting Series Comparing and Contrasting Basal Insulin Strategies

Making the Connection

1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT. Friday, October 27, Zuckerman Research Center, New York City

FRONTLINE CARDIOLOGY. APRIL 21, 2018 College Park Marriott Hotel & Conference Center Hyattsville, MD COURSE DIRECTORS: COURSE CO-DIRECTOR:

ASCO Review Wednesday, June 27, Highlights of the National Meeting

Ovarian Cancer Conference

CAR T Cell Therapies Workshop

Imaging & Care of the Breast Cancer Patient

Making the Connection Between Patients and Providers

PERSONALIZED PSYCHO-ONCOLOGY

Hampton Roads Oncology Update 2019:

MANAGEMENT OF A SLEEP DISORDERS CENTER:

ULTMANN CHICAGO LYMPHOMA SYMPOSIUM

MDS: Who gets it and how is it diagnosed?

Updates in Alcoholic Liver Disease

Breast Cancer Update: From Screening Through Treatment To Survivorship

Making the Connection

Fourth Annual Advances in Pulmonary Medicine

Multidisciplinary Genitourinary Oncology Course:

Hospital Medicine 2018:

CLINICAL APPLICATION OF CAR T CELLS

KEYNOTE PRESENTATION. Edward A Stadtmauer, MD and Patricia Mangan, MSN, CRNP

Breast Cancer Management 2018

Emerging Opportunities Enhancing Awareness of Clinical Trials

EXHIBITOR PROSPECTUS. 22nd Annual. January 31- February 2, 19 Park City, Utah

Sponsorship. Opportunities

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

PROOF. Advances in Oncology th Annual. September 30 - October 1, 2016 Hyatt Regency Sacramento, CA CONFERENCE DIRECTORS

SPINE. Oncology Symposium. Multidisciplinary JUNE 3-4, Conference Location:

Current Topics in Breast Cancer Symposium

In multiple published papers digital breast

Making the Connection

No Other Company Discloses Higher Transplant Survival Rate. Infusions For Emerging Treatments. Date of Use. Recipient Age (yrs)

Conference Program. Genomic heterogeneity in localized lung cancer Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX

December 2, Taube Foundation Huntington s Disease Symposium. Course Chair Stanley B. Prusiner, MD Course Fee $25

Mayo Clinic Pancreatic and Hepato-Biliary Cancer Symposium 2018

International Conference on Advances in Hematology and Oncology

RECENT ADVANCES IN ONCOLOGY FOR THE PRIMARY CARE PHYSICIAN PHILADELPHIA

Symposium on STROKE. & Cerebrovascular Diseases. Saturday, 21 October 2017 Éilan Hotel & Spa San Antonio, Texas

Advanced Cranial Radiosurgery

The 2018 Northwestern Medicine Neuro-Oncology CME Symposium

1st North American Workshop on Neuropathology and Epilepsy Surgery

A Comprehensive Strategy on the Modern Management of Type 1 and Type 2 Diabetes

SESPRS 2016 ATLANTA OCULOPLASTIC SYMPOSIUM

Epilepsy Update 2007

BREAST CANCER 2013: Seeing the Future

NOTE: PODCAST/MP3 PROGRAM 1

2016 Head & Neck Cancer:

Annual Report Division of Hematology Department of Medicine, Jewish General Hospital April 1, December 31, 2011

CLINICAL ENDOCRINOLOGY FOR PRIMARY CARE

Advances in Oncology th Annual. October 10-11, 2014 Hyatt Regency Sacramento, CA CONFERENCE DIRECTORS

EXHIBITOR AND SPONSORSHIP PROSPECTUS. HTRS 2015 Scientific Symposium April 16-18, 2015 Hilton New Orleans Riverside New Orleans, LA

Designated for SA-CME. Release Date: August 1, A CME Teaching Activity 2016 Radiology After Five: How to Make Night and Weekend Call a Success!

Transcription:

Part of the Oncology Learning Network Now Offering 2 Locations March 22 23, 2019 Marina del Rey Marriott Marina del Rey, California April 5 6, 2019 Crowne Plaza Times Square Manhattan, New York Where Debate & Discussion Translate to Breakthroughs Greatdebatesinhema.com MARCH 22 23, 2019 MARINA DEL REY, CALIFORNIA APRIL 5 6, 2019 MANHATTAN, NEW YORK

2 Days of Unparalleled Education. Interactive Format. Practical Implications. Join us for a unique educational experience. In this 2-day debate-style series, nationally recognized thought leaders take opposing sides on clinical and sometimes controversial topics currently disrupting the practice of hematology and oncology. This one-of-a-kind hematology conference provides a substantial curriculum covering the broad continuum of: Multiple Myeloma Acute Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Not So Benign Hematology Myelodysplastic Syndromes Myeloproliferative Neoplasms Lymphoproliferative Diseases Endorsements Exhibits Several options are available to companies who wish to exhibit at this meeting. For more information, please contact: Kathleen St. Jean, Director, Business Development at k.stjean@imedex.com. GREAT DEBATES & UPDATES IN HEMATOLOGIC MALIGNANCIES GREATDEBATESINHEMA.COM

Meet the Chairs John P. Leonard, MD Center for Lymphoma and Myeloma Weill Cornell Medicine Joseph Mikhael, MD, MEd, FRCPC City of Hope Cancer Center Translational Genomics Research Institute Phoenix, Arizona David P. Steensma, MD Dana-Farber Cancer Institute Harvard Medical School Boston, Massachusetts Meet the Faculty Rafael Bejar, MD, PhD UC San Diego Moores Cancer Center San Diego, California James Bussell, MD + Weill Cornell Medicine Naval Daver, MD MD Anderson Cancer Center University of Texas Houston, Texas Daniel J. DeAngelo, MD, PhD + Dana-Farber Cancer Institute Harvard Medical School Boston, Massachusetts Jonathan Friedberg, MD + University of Rochester Rochester, New York Richard R. Furman, MD + Weill Cornell Medicine Sarah A. Holstein, MD, PhD* University of Nebraska Medical Center Omaha, Nebraska Jonathon Kauffman, MD Emory University Atlanta, Georgia Brea C. Lipe, MD + University of Rochester Rochester, New York Jaroslaw P. Maciejewski, MD, PhD Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio Ruben A. Mesa, MD + Mays Cancer Center UT Health San Antonio MD Anderson San Antonio, Texas Jerald P. Radich, MD Fred Hutchinson Cancer Research Center Seattle, Washington Noopur Raje, MD + Massachusetts General Hospital Boston, Massachusetts Gail J. Roboz, MD + Weill Cornell Medicine David Sallman, MD + H. Lee Moffitt Cancer Center Tampa, Florida Michael R. Savona, MD Vanderbilt-Ingram Cancer Center Nashville, Tennessee Saad Z. Usmani, MD, FACP + Levine Cancer Institute Charlotte, North Carolina Speaker Key: *: CA only; +: NY only MARCH MARCH 22 23, 22 23, 2019 MARINA 2019 MARINA DEL REY, DEL CALIFORNIA REY, CALIFORNIA APRIL 5 6, APRIL 2019 5 6, MANHATTAN, 2019 MANHATTAN, NEW YORK NEW YORK

DAY I, 2019 Session I: Plasma Cell Disorders Session Chair: Joseph Mikhael, MD, MEd, FRCPC, FACP 08:00 AM Welcome and pre-activity audience survey 08:10 AM Novel Small Molecule Inhibitors in Multiple Myeloma 08:30 AM Emerging Immunotherapies in Multiple Myeloma 08:50 AM Update: Frontline Therapy 09:10 AM Update: Maintenance Therapy 09:30 AM Late-Breaking Lecture 09:50 AM Break 10:10 AM R/R Multiple Myeloma: Combination Therapy/Three Drugs/Four Drugs 10:30 AM Debate: MRD 11:00 AM Optimizing Dosing Regimen in MM 11:20 AM Final remarks and post-activity audience survey 11:30 AM Lunch Session II: Chronic Lymphocytic Leukemia Session Chair: John P. Leonard, MD 01:00 PM Introduction and pre-activity audience survey 01:10 PM Novel Treatment Options in CLL 01:30 PM Late-Breaking Lecture 01:50 PM Late-Breaking Lecture 02:10 PM Sequencing Monotherapy vs. Combination Therapy 02:30 PM Post-activity audience survey Session III: AML/ALL Session Chair: David P. Steensma, MD 02:40 PM Pre-activity audience survey 02:50 PM Update: New Drugs for ALL 03:10 PM Case: MRD+ ALL in Remission 03:30 PM Update: New Drugs for AML 03:50 PM Post-activity audience survey 04:00 PM Break Session IV: MPN/MDS Session Chair: David P. Steensma, MD 04:20 PM Pre-activity audience survey 04:30 PM Late-Breaking Lecture 04:50 PM Late-Breaking Lecture 05:10 PM Update: New Treatments for MPN/MDS 05:30 PM Final remarks and post-activity audience survey 05:40 PM Adjourn GREAT DEBATES & UPDATES IN HEMATOLOGIC MALIGNANCIES

Day II, 2019 Session V: Lymphoma I Session Chair: John P. Leonard, MD 8:15 AM Welcome and pre-activity audience survey 8:25 AM DLBCL 8:45 AM Debate: TBD 9:15 AM Update: Upfront and Maintenance Therapy in Follicular Lymphoma 9:35 AM Update: Relapsed/Refractory Follicular Lymphoma 9:55 AM CAR-T in Lymphoma 10:15 AM Post-activity audience survey 10:25 AM Break Session VI: Lymphoma II Session Chair: John P. Leonard, MD 10:45 AM Pre-activity audience survey 10:55 AM HL (Check Point Inhibitors in chl and PMBCL) 11:15 AM Late-Breaking Lecture 11:35 AM NHL 11:55 AM Debate: MCL 12:25 PM Late-Breaking Lecture 12:45 PM Post-activity audience survey 01:05 PM Lunch Session VII: CML Session Chair: David P. Steensma, MD 2:35 PM Pre-activity audience survey 2:40 PM Treatment Options for Ph+ CML 3:00 PM Debate: CML 3:30 PM Late-Breaking Lecture 3:50 PM Post-activity audience survey 3:55 PM Break Session VIII: Not-So-Benign Hematology Session Chair: David P. Steensma, MD 4:15 PM Pre-activity audience survey 4:20 PM Update: ITP Treatment 4:40 PM Aplastic Anemia 5:00 PM Late-Breaking Lecture 5:20 PM Final remarks and post-activity audience survey 5:30 PM Adjourn MARCH 22 23, 2019 MARINA DEL REY, CALIFORNIA APRIL 5 6, 2019 MANHATTAN, NEW YORK

Who Should Attend These live educational activities are designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with multiple myeloma, lymphoma, chronic lymphocytic leukemia, and acute myeloid leukemia. Hematologists Medical Oncologists Physicians Physician Assistants Physicians-in- Training Oncology Nurses Pharmacists Continuing Education Imedex is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Imedex. NACCME is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Group Discounts available for attendees from the same practice! Support Several options are available to companies interested in supporting this conference/symposium. For more information, please contact Dan Alba, Senior Director, Educational Strategy, Hematology & Oncology at d.alba@imedex.com or Shannon Stevenson, Director of Educational Strategy at s.stevenson@imedex.com. Credit Statements These conferences will offer continuing education credit for physicians, pharmacists, nursing professionals, and physician assistants. ABIM MOC will also be available. Please visit https:// hematologicmalignancies. oncnet.com/continuingeducation for the most up-to-date information. It is anticipated that this activity will award 13 credits/contact hours. GREAT DEBATES & UPDATES IN HEMATOLOGIC MALIGNANCIES GREATDEBATESINHEMA.COM

More Locations, Education, and Value Marina del Rey Marriott 4100 Admiralty Way Marina del Rey, CA 90292 Special Room Rate: $229.00 per night, plus tax. Phone: (310) 301-3000 www.marinadelreymarriott.com Crowne Plaza Times Square Manhattan 1605 Broadway New York, NY 10019 Special Room Rate: $251.00 per night, plus tax. Phone: (212) 977-4000 www.cpmanhattantimessquare.com Ways To Register Online: Greatdebatesinhema.com Phone: (800) 233-0957 International: (678) 242-0906 Rates Physicians PhD Pharmacists Nurse Practitioners Physician Assistants Nurses Residents Students Fellows Pharmaceutical Industry Early $279 $169 $89 $499 Regular $329 $199 $99 $499 For assistance, please contact registration@imedex.com. To reserve the best rates, sign-up before: Marina del Rey: February 22, 2019 New York: March 5, 2019 Enroll in the Great Debates & Updates Value Package and save by signing up for multiple locations at once!

Where Debate & Discussion Translate to Breakthroughs March 22 23, 2019 Marina del Rey, California April 5 6, 2019 Reserve your seat today: Greatdebatesinhema.com 11675 Rainwater Drive, Suite 600, Alpharetta, GA